Mckesson 

R$801
370
+R$0+0% Friday 16:36

통계

낮 최고
-
낮음
-
52W 높음
-
52W 낮음
-
거래량
-
평균 거래량
-
시가 총액
279.62B
주가수익률
27.27
배당수익률
0.31%
배당금
2.46

예정

배당금

0.31%배당수익률
10년 성장률
해당 없음
5년 성장률
해당 없음
3년 성장률
-0.46%
1년 성장률
-1.51%

수익

7May확인됨
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
5.87
6.49
7.12
7.74
예상 EPS
6.36
실제 EPS
6.18

다른 인물도 팔로우하고 있습니다

이 목록은 Stock Events에서 M1CK34.SA을(를) 팔로우하는 사람들의 워치리스트에 기반한 것입니다. 이는 투자 권유가 아닙니다.

경쟁자

이 목록은 최근 시장 이벤트에 기반한 분석입니다. 투자 권장사항이 아닙니다.

개요

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Show more...
CEO
Mr. Brian S. Tyler Ph.D.
직원
58000
국가
United States
ISIN
BRM1CKBDR004

목록